Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 4,444,445 | 1,392,303 | -3,052,142 | $1.45B | $634.89M | 90.64% | -$814.40M |
| Intellia Therapeutics, Inc.(NTLA) | 3,702,995 | 3,702,995 | 0 | $34.73M | $63.95M | 9.13% | +$29.22M |
| Adverum Biotechnologies, Inc. | 180,909 | 180,909 | 0 | $389.0K | $819.5K | 0.12% | +$430.6K |
| Adicet Bio, Inc. | 968,183 | 968,183 | 0 | $590.6K | $784.4K | 0.11% | +$193.8K |